Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Brown

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Transgenic Research|January 15, 2010
Spatial monitoring of toxicity in HMOX-LacZ transgenic miceRachel Young, C Roland Wolf, Ken Brown, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|February 26, 2011
Evaluation of RNA-knockdown strategies for modulation of cytochrome P450 reductase activity in mouse hepatocytesNeil Cw Mackenzie, Simon G Lillico, Ken Brown, et al.
Toxicology and Applied Pharmacology|January 25, 2008
p21-LacZ reporter mice reflect p53-dependent toxic insultDouglas B Vasey, C Roland Wolf, Thomas MacArtney, et al.
Healthcare Management Forum|December 6, 2005
Physicians' perceptions of integration in three Western Canada Health RegionsOlive H Triska, John Church, Douglas Wilson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 1, 2007
A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetesCharlotte Bebb, Denise Kendrick, Carol Coupland, et al.
The Journal of Investigative Dermatology|January 11, 2008
Illuminating role of CYP1A1 in skin functionJo M Rowe, Claire Welsh, Romi N Pena, et al.
Nature|December 14, 2004
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor geneJian-Hua Mao, Jesus Perez-Losada, Di Wu, et al.
Human Molecular Genetics|July 3, 2003
Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disordersGeorge Bakirtzis, Rukhsana Choudhry, Trond Aasen, et al.
Journal of Cardiovascular Risk|December 13, 2002
Evaluation of a cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery diseaseKevin F Fox, David A Wood, Melissa Wright, et al.
Pharmaceutical Research|June 29, 2010
Rapid intradermal delivery of liquid formulations using a hollow microstructured arrayScott A Burton, Chin-Yee Ng, Ryan Simmers, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Transgenic Research|January 15, 2010
Spatial monitoring of toxicity in HMOX-LacZ transgenic miceRachel Young, C Roland Wolf, Ken Brown, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|February 26, 2011
Evaluation of RNA-knockdown strategies for modulation of cytochrome P450 reductase activity in mouse hepatocytesNeil Cw Mackenzie, Simon G Lillico, Ken Brown, et al.
Toxicology and Applied Pharmacology|January 25, 2008
p21-LacZ reporter mice reflect p53-dependent toxic insultDouglas B Vasey, C Roland Wolf, Thomas MacArtney, et al.
Healthcare Management Forum|December 6, 2005
Physicians' perceptions of integration in three Western Canada Health RegionsOlive H Triska, John Church, Douglas Wilson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 1, 2007
A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetesCharlotte Bebb, Denise Kendrick, Carol Coupland, et al.
The Journal of Investigative Dermatology|January 11, 2008
Illuminating role of CYP1A1 in skin functionJo M Rowe, Claire Welsh, Romi N Pena, et al.
Nature|December 14, 2004
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor geneJian-Hua Mao, Jesus Perez-Losada, Di Wu, et al.
Human Molecular Genetics|July 3, 2003
Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disordersGeorge Bakirtzis, Rukhsana Choudhry, Trond Aasen, et al.
Journal of Cardiovascular Risk|December 13, 2002
Evaluation of a cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery diseaseKevin F Fox, David A Wood, Melissa Wright, et al.
Pharmaceutical Research|June 29, 2010
Rapid intradermal delivery of liquid formulations using a hollow microstructured arrayScott A Burton, Chin-Yee Ng, Ryan Simmers, et al.
Pageof 3